Advanced Crystal Shape Descriptors for Precision Particulate Design, Characterisation and Processing (Shape4PPD) | University of Leeds |
968,184
|
AI for Chemistry: AIchemy | University of Liverpool |
5,526,001
|
CMMI-EPSRC - Right First Time Manufacture of Pharmaceuticals (RiFTMaP) | University of Sheffield |
1,543,633
|
Dialling up performance for on demand manufacturing | University of Nottingham |
5,865,536
|
DigiScale: Digitally driven scale up of chemical processes | University of Leeds |
970,893
|
Enabling Next Generation Additive Manufacturing | University of Nottingham |
5,852,466
|
'EPSRC and SFI Centre for Doctoral Training in Transformative Pharmaceutical Technologies | University of Nottingham |
6,714,348
|
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture) | UCL |
6,156,442
|
EPSRC Centre for Doctoral Training in Enhancing Human Interactions and Collaborations with Data and Intelligence Driven Systems | Swansea University |
5,279,589
|
EPSRC Centre for Doctoral Training in Molecules to Product | University of Leeds |
5,335,774
|
EPSRC Centre for Doctoral Training in Next Generation Synthesis & Reaction Technology | Imperial College London |
6,428,538
|
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB | UCL |
10,851,090
|
Late-Stage Bioisosterism: Small Ring Carbocations for Late-Stage Functionalisation and Medicinal Chemistry | Imperial College London |
525,229
|
Leveraging sulfinates for heterocycle cross-electrophile coupling | University of Oxford |
288,987
|
Modelling, Validation and Application of Triboelectrification | University of Leeds |
1,451,922
|
New Routes to fluorocarbons using fluoroboranes | University of Edinburgh |
438,549
|
RELOAD: REspiratory disease progression through LOngitudinal Audio Data machine learning | University of Cambridge |
608,960
|
Transforming the Objective Real-world measUrement of Symptoms (TORUS) | University of Bristol |
6,177,330
|
Total Number of Grants: 18
Total Value of Grants: £70,983,472
The grant value may include the cost of access to facilities (these funds are not awarded to the grant holding organisation).